Viruses · 2021 · 23 citations · 25 references
Life SciencesInfectious DiseasesMolecular BiologyGlycobiologyMolecular VirologyVirologyAnimal VirusesAntiviral ImmunityAntiviral TherapyAquatic Animal Infectious DiseasesViral InfectionsAntiviral TherapeuticsFucoidanMarine-derived Antiviral CompoundsNorovirus InfectionVirus-like Particle Therapeutics
Human noroviruses (hNoVs) cause heavy disease burden worldwide and there is no clinically approved vaccination or antiviral hitherto. In this study, with the use of a zebrafish larva in vivo platform, we investigated the anti-hNoV potentials of fucoidan (from brown algae Fucus vesiculosus) and 2′-Fucosyllactose (2′-FL). As a result, although both fucoidan and 2′-FL were able to block hNoV GII.4 virus-like particle (VLPs) from binding to type A saliva as expected, only fucoidan, but not 2′-FL, was able to inhibit the replication of hNoV GII.P16-GII.4 in zebrafish larvae, indicating the possible needs of higher molecular weights for fucosylated carbohydrates to exert anti-hNoV effect.
25
Replication of human noroviruses in stem cell–derived human enteroids
Khalil Ettayebi, Sue E. Crawford, Kosuke Murakami et al. · Science · 2016 · 1.3K citations · Full text
An automated genotyping tool for enteroviruses and noroviruses
Annelies Kroneman, Harry Vennema, Koen Deforche et al. · Journal of Clinical Virology · 2011 · 814 citations
A robust human norovirus replication model in zebrafish larvae
Jana Van Dycke, Annelii Ny, Nádia Conceição‐Neto et al. · PLoS Pathogens · 2019 · 171 citations · Full text